Guangdong Hybribio Biotech Co.,Ltd.
SZSE:300639.SZ
8.67 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 764.932 | 1,024.776 | 521.973 | 390.958 | 257.333 | 62.797 | 185.76 | 51.413 | 47.25 | 107.653 | 102.158 | 23.607 |
| Short Term Investments
| 307.055 | 387.057 | 677.144 | 860 | 5 | -26.191 | -16.259 | 0 | 0 | 0 | 0 | 12 |
| Cash and Short Term Investments
| 1,071.987 | 1,411.832 | 1,199.116 | 1,250.958 | 262.333 | 62.797 | 185.76 | 51.413 | 47.25 | 107.653 | 102.158 | 23.607 |
| Net Receivables
| 1,890.591 | 2,725.397 | 1,182.835 | 576.861 | 337.935 | 265.928 | 204.55 | 150.913 | 124.842 | 90.438 | 62.902 | 45.134 |
| Inventory
| 99.558 | 118.739 | 147.143 | 96.305 | 43.414 | 40.203 | 32.506 | 34.766 | 29.266 | 23.602 | 14.875 | 14.682 |
| Other Current Assets
| 114.79 | 550.66 | 23.373 | 38.002 | 30.049 | 20.879 | 269.174 | 14.197 | 10.851 | 9.951 | 6.866 | 16.287 |
| Total Current Assets
| 3,176.925 | 4,400.278 | 2,552.467 | 1,962.126 | 664.63 | 709.306 | 697.251 | 248.909 | 205.669 | 230.345 | 186.06 | 104.533 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 1,437.358 | 1,316.959 | 1,167.564 | 598.453 | 413.401 | 346.781 | 278.996 | 269.862 | 231.052 | 100.128 | 41.609 | 20.779 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 276.801 | 218.767 | 124.712 | 118.764 | 104.583 | 31.304 | 31.271 | 31.16 | 35.047 | 30.898 | 34.275 | 37.667 |
| Goodwill and Intangible Assets
| 276.801 | 218.767 | 124.712 | 118.764 | 104.583 | 31.304 | 31.271 | 31.16 | 35.047 | 30.898 | 34.275 | 37.667 |
| Long Term Investments
| 533.125 | 134.92 | -403.338 | -784.022 | 10.421 | 36.941 | 23.742 | 12.34 | 6.761 | 5.713 | 2.078 | 1.357 |
| Tax Assets
| 195.346 | 170.201 | 29.204 | 21.066 | 30.613 | 21.401 | 20.128 | 14.538 | 10.341 | 5.369 | 4.601 | 2.882 |
| Other Non-Current Assets
| 106.236 | 490.001 | 760.776 | 940.577 | 73.32 | 42.526 | 18.253 | 2.344 | 4.955 | 13.212 | 2.4 | 2.029 |
| Total Non-Current Assets
| 2,548.866 | 2,330.848 | 1,678.918 | 894.838 | 632.338 | 478.953 | 372.391 | 330.243 | 288.157 | 155.319 | 84.962 | 64.714 |
| Total Assets
| 5,725.791 | 6,731.126 | 4,231.385 | 2,856.964 | 1,296.968 | 1,188.259 | 1,069.642 | 579.152 | 493.826 | 385.664 | 271.023 | 169.247 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 143.666 | 466.69 | 221.147 | 86.2 | 35.922 | 25.762 | 17.322 | 16.396 | 31.549 | 11.144 | 11.082 | 12.175 |
| Short Term Debt
| 2.119 | 98.484 | 151.5 | 75.272 | 0 | 0 | 0 | 10 | 0 | 0 | 26.53 | 0 |
| Tax Payables
| 78.098 | 371.219 | 104.479 | 23.014 | 14.583 | 14.477 | 10.291 | 4.853 | 4.963 | 4.981 | 4.702 | 3.77 |
| Deferred Revenue
| 0 | 22.156 | 296.33 | 139.656 | 4.18 | 3.31 | 1.131 | 31.128 | 25.6 | 23.928 | 22.662 | 14.709 |
| Other Current Liabilities
| 284.034 | 426.439 | 187.305 | 121.444 | 55.713 | 56.194 | 56.905 | 29.375 | 23.814 | 23.526 | 25.611 | 20.693 |
| Total Current Liabilities
| 507.916 | 1,362.832 | 677.586 | 303.022 | 106.217 | 96.432 | 84.518 | 60.624 | 60.327 | 39.651 | 67.925 | 36.638 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 45.671 | 30.535 | 26.862 | 11.688 | 0.232 | 0.14 | 0 | 0 | 0 | 0 | 10 | 0.277 |
| Deferred Revenue Non-Current
| 11.82 | 14.132 | 16.565 | 18.913 | 5.331 | 10.704 | 12.999 | 15.219 | 17.619 | 0.635 | 1.045 | 1.36 |
| Deferred Tax Liabilities Non-Current
| 61.602 | 96.743 | 35.359 | 0.584 | 0.548 | 0.893 | 1.225 | 1.643 | 2.169 | 0.465 | 0.559 | 0.685 |
| Other Non-Current Liabilities
| 11.866 | 0 | 0 | 18.913 | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 | 0 |
| Total Non-Current Liabilities
| 119.139 | 141.41 | 78.786 | 19.664 | 6.111 | 11.738 | 14.224 | 16.862 | 19.788 | 1.411 | 11.715 | 2.323 |
| Total Liabilities
| 627.055 | 1,504.242 | 756.373 | 322.686 | 112.328 | 108.17 | 98.742 | 77.487 | 80.115 | 41.062 | 79.64 | 38.961 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 36.802 | 49.808 | 0 | 0 | 0 | 0 | 1.383 | 0 |
| Common Stock
| 649.15 | 439.516 | 293.894 | 235.382 | 217.381 | 182.008 | 91.017 | 67.5 | 67.5 | 67.5 | 62.15 | 59 |
| Retained Earnings
| 3,159.797 | 3,200.518 | 1,581.388 | 808.061 | 495.76 | 394.168 | 343.484 | 261.069 | 185.484 | 121.112 | 59.337 | 31.514 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 271.796 | 75.008 | 11.032 | -36.802 | -49.808 | 0.011 | 160.92 | 159.023 | 0 | -1.383 | 0 |
| Other Total Stockholders Equity
| 1,052.33 | 1,266.533 | 1,319.103 | 1,354.721 | 405.379 | 441.081 | 526.133 | 160.92 | 159.023 | 155.99 | 71.279 | 39.772 |
| Total Shareholders Equity
| 4,861.277 | 4,906.567 | 3,194.385 | 2,390.534 | 1,081.718 | 967.449 | 960.6 | 489.489 | 412.007 | 344.602 | 191.383 | 130.286 |
| Total Equity
| 5,098.736 | 5,226.884 | 3,475.013 | 2,534.278 | 1,184.64 | 1,080.088 | 970.9 | 501.665 | 413.711 | 344.602 | 191.383 | 130.286 |
| Total Liabilities & Shareholders Equity
| 5,725.791 | 6,731.126 | 4,231.385 | 2,856.964 | 1,296.968 | 1,188.259 | 1,069.642 | 579.152 | 493.826 | 385.664 | 271.023 | 169.247 |